Genetic studies have revealed that both well-known genes such as filaggrin (FLG) and rare variants affecting signaling pathways (e.g., signal transducer and activator of transcription 6 (STAT6), janus kinase 1 (JAK1)) are implicated in AD pathogenesis [23]. This evidence concerns the gene JAK1 and Alzheimer disease.